Micillo, Teresa (2020) Impact of dimethyl fumarate treatment on immune tolerance during Multiple Sclerosis. [Tesi di dottorato]

[thumbnail of PhD_thesis_Teresa_Micillo_Biologia_XXXII_ciclo.pdf]
Preview
Text
PhD_thesis_Teresa_Micillo_Biologia_XXXII_ciclo.pdf

Download (2MB) | Preview
Item Type: Tesi di dottorato
Resource language: English
Title: Impact of dimethyl fumarate treatment on immune tolerance during Multiple Sclerosis
Creators:
Creators
Email
Micillo, Teresa
ter.micillo@gmail.com
Date: 2020
Number of Pages: 56
Institution: Università degli Studi di Napoli Federico II
Department: Biologia
Dottorato: Biologia
Ciclo di dottorato: 32
Coordinatore del Corso di dottorato:
nome
email
Cozzolino, Salvatore
cozzolin@unina.it
Tutor:
nome
email
Porcellini, Antonio
UNSPECIFIED
Date: 2020
Number of Pages: 56
Keywords: Immunology, Dimethyl fumarate, Multiple Sclerosis.
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/04 - Patologia generale
Date Deposited: 26 Mar 2020 08:34
Last Modified: 08 Nov 2021 12:23
URI: http://www.fedoa.unina.it/id/eprint/13130

Collection description

Dimethyl fumarate (DMF) is a first line oral treatment for relapsing-remitting multiple sclerosis (RR-MS) patients. Although it is known that DMF have protective antioxidant properties against brain and spinal cord damage during MS, its precise mechanism of action remains still elusive. Here, we evaluated the immunological effects of DMF treatment in RR-MS patients and we investigated the impact of DMF on metabolic profile of T cells. We observed that DMF treatment results in reduction of number of total lymphocytes and of CD19+ B cells, CD4+ and CD8+ T cells. In addition, DMF treatment is associated with a specific reduction of the memory T cells. Furthermore, we found that DMF treatment was able to increase the proliferative capacity of Treg cells over time and to restore the altered metabolic profile of T cells in RR-MS patients. Taken together, these data suggest a novel mechanism of action for DMF by modulation of the metabolic pathways of T cells that could lead to an improvement of immune tolerance during autoimmunity.

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item